While I definitely consider a key resignation without adequate explanation a red flag, I don't have enough experience with such an event to say it catagorically ends badly. It sounds like you would advise selling ASAP. I wonder if this could be considered a rule to abide by?
It's not as bad as the disclosure of a problem with their drug would be, but it has me a bit rattled. I appreciate the input and will be watching the stock with this in mind.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.